About Triventures
Triventures is a venture capital firm founded in 2010. It is primarily based out of Herzliya, Israel. As of Sep 2025, Triventures has invested in 40 companies. It primarily invests in Series A round in Israel based startups. Its investments are spread across a wide range of sectors from HealthTech to Life Sciences and Enterprise Applications. Most recently it participated in the $***** Seed round of Descope Overall, Triventures portfolio has seen 1 unicorn and 11 acquisitions including key companies like BioProtect, Vi and CathWorks. A lot of funds co-invest with Triventures, with names like Sanara Capital sharing a substantial percentage of its portfolio. Triventures has team of 4 people including 3 partners.Key Metrics
Team Members
Portfolio Sectors
Portfolio Locations
Rounds of Entry
Series A, Series B & 3 more
Portfolio Acquisitions
Portfolio Unicorns
Portfolio Soonicorns
Triventures' List of Top Investments
Triventures has a portfolio of 40 companies, one of which is a Unicorn. Their most notable investments are in LifeBEAM and V-Wave.Their portfolio spans across Israel, United States, Ireland and 1 more locations. They have invested in HealthTech, Life Sciences, Enterprise Applications and 10 other sectors, across stages such as Series A, Series B and 3 more. Here is the list of top investments by Triventures:
1. AIdoc
Developer of clinical AI solutions for healthcare imaging and patient management. The company offers a platform designed for seamless integration into existing IT infrastructure. It provides tools for care coordination, patient identification, and systems integrations. The company focuses on streamlining workflows and centralizing patient management across various medical specialties.
Key facts about AIdoc
- Founded Year: 2016
- Location: New York City (United States)
- Valuation: $*****
- Stage: Series E
- Total Funding till date: $534M
- Employee Count: 624 as on Sep 30, 2026
- Investors: Goldman Sachs, TCV and 35 Others
- Latest Funding Round: Series E, Apr 29, 2026, $*****
- Highlight: Editors' Pick
2. Griffin
Provider of banking infrastructure and embedded financial product software interfaces. This entity offers application programming interfaces that allow businesses to integrate bank accounts, payment processing, and financial management tools into their own digital platforms. The technology supports the creation of accounts for safeguarding client funds, managing operational business banking, and facilitating domestic payment transfers. Additional capabilities include automated identity verification and financial crime prevention checks to assist with regulatory compliance. The infrastructure is designed to support various financial use cases, including lending, wealth management, and payroll services, through a cloud-based architecture.
Key facts about Griffin
- Founded Year: 2017
- Location: London (United Kingdom)
- Annual Revenue: £1M - £10M as on Sep 30, 2025
- Valuation: $*****
- Stage: Series A
- Total Funding till date: $67.4M
- Employee Count: 148 as on Sep 30, 2026
- Investors: EQT, NJF Capital and 40 Others
- Latest Funding Round: Series A, Nov 21, 2024, $*****
- Highlight: Editors' Pick
3. BioProtect
BioProtect is developing radiation protection technology. The company has developed a BioProtect/ ProSpace Balloon System which acts as a spacer and pushes healthy tissue away from the high-dose radiation field for patients receiving radiotherapy for prostate cancer.
Key facts about BioProtect
4. GlassesUSA
Online retailer of eyewear. The product catalog includes prescription eyeglasses, sunglasses, and contact lenses. It stocks products of brands such as Ray-Ban, Versace, Prada, Arnette, Tom Ford, and more. Users can search for the products using different filters such as shape, lenses, brand, frame & material. It also allows virtual try-on of the products. It provides free shipping.
Key facts about GlassesUSA
- Founded Year: 2008
- Location: New York City (United States)
- Stage: Series C
- Total Funding till date: $95M
- Employee Count: 190 as on Sep 30, 2026
- Investors: Triventures, Viola Group and 1 Other
- Latest Funding Round: Series C, Jan 21, 2021, $*****
- Highlight: Editors' Pick
5. Cala Health
Developer of a wearable non-invasive neuromodulation device. The company has developed a neuromodulation device that aims to provide relief of hand tremors in adults with essential tremors. It combines a watch-like device with an implantable sensor that externally stimulates peripheral nerves to reduce the same. The company has also developed a portable medical device with sensors to monitor the physical movement of a patient wearing or carrying the device.
Key facts about Cala Health
- Founded Year: 2013
- Location: Stanford (United States)
- Valuation: $*****
- Stage: Series D
- Total Funding till date: $257M
- Employee Count: 127 as on Aug 31, 2026
- Investors: AME Cloud Ventures, Innovatus Capital Partners and 29 Others
- Latest Funding Round: Conventional Debt, Apr 21, 2026, $*****
- Highlight: Editors' Pick
Triventures' Year-on-Year Investment Trends
Triventures has invested in 40 companies over the last 15 years, with an average of 2 new investments annually in the last 10 years. In 2025, it made 1 investment. Its most recent first time investment was in Descope and most recent follow-on round was in Cala Health.Year | No. of Investments | ||
|---|---|---|---|
1st Round | Follow-on | Total | |
2026 (YTD) | 0 | 0 | 0 |
2025 | 1 | 0 | 1 |
2024 | 1 | 4 | 5 |
2023 | 1 | 1 | 2 |
2022 | 2 | 2 | 4 |
2021 | 6 | 5 | 11 |
2020 | 3 | 1 | 4 |
2019 | 4 | 0 | 4 |
2018 | 2 | 1 | 3 |
2017 | 4 | 3 | 7 |
Triventures' Investments by Stage
Triventures has made 16 investments in Series A stage with an average round size of $9.8M, 8 investments in Series B stage with an average round size of $17.1M, 6 investments in Seed stage with an average round size of $10.5M, 3 investments in Series C stage with an average round size of $54.2M and 1 investment in Series D stage with an average round size of $25M.Stage of entry | No. of Investments |
|---|---|
Series A | 16 |
Series B | 8 |
Seed | 6 |
Series C | 3 |
Series D | 1 |
Note: We have considered here, only first round of investments
Triventures' Investments by Sector
Triventures has a diverse portfolio, with companies operating in the Enterprise Applications, HealthTech, Life Sciences, High Tech and Vertical SaaS. Notably, it has invested in 38 Tech companies, 33 Enterprise (B2B) companies, 22 Software companies and at least 13 companies focusing on Consumer (B2C).Sector | No. of Investments |
|---|---|
Enterprise Applications | 15 |
HealthTech | 14 |
Life Sciences | 14 |
High Tech | 7 |
Vertical SaaS | 7 |
Others | 20 |
Note: We have considered here, only first round of investments
Triventures' Investments by Geography
Triventures has made most investments in Israel (17), followed by United States where it has made 15 investments.Country | No. of Investments |
|---|---|
Israel | 17 |
United States | 15 |
Ireland | 1 |
United Kingdom | 1 |
Note: We have considered here, only first round of investments
Triventures' recent investments
Triventures has not made any investment in 2026 so far.Here are the most recent investments by Triventures:
Filter this listDate | Company | Location | Round Details | Round Amount | Co-Investors |
|---|---|---|---|---|---|
Sep 30, 2025 | United States | Seed | 8397 | [+4] | |
Dec 09, 2024 | United States | Series D | 9204 | [+11] | |
Nov 21, 2024 | Israel | Series C | 5937 | ||
Oct 15, 2024 | Israel | Series A | 8054 | [+9] | |
Mar 26, 2024 | United States | Series C | 6957 | [+5] |
Unicorns in Triventures' Portfolio
Triventures has 1 unicorn in its portfolio - Vi. The most recent unicorn in their portfolio is Vi which became a unicorn in 2026, 10 years after Triventures first invested in it.Here is a list of unicorns in Triventures' portfolio:
Tracxn Score | Company | Short Description | Founded year | Sector | Location | Company Stage | First Investment/ Acquisition Details |
|---|---|---|---|---|---|---|---|
61 | Provider of AI SaaS platform for health outcome and financial returns | 2016 | New York City | Series A | otluzhv |
Acquired companies in Triventures' Portfolio
11 companies from Triventures' portfolio have been acquired. The most recent acquisition was BioProtect in May 2026 by Olympus for $*****.Here are Triventures' portfolio companies that got acquired most recently:
Company | Acquisition Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
May 26, 2026 | Sep 22, 2020 | Series D | 7737 | |
Apr 20, 2026 | Oct 02, 2017 | Series B | 4786 | |
May 12, 2025 | May 15, 2018 | Series A | 8721 | |
Aug 20, 2024 | Jan 11, 2016 | Series B | 9444 | |
Jan 31, 2023 | Mar 02, 2021 | Series A | 2065 |
Team profile of Triventures
Triventures has a team of 4 members including 3 Partners and 1 Principal located in United States and Israel. Triventures' team does not sit on the board of any company as of now.Here is a list of all team members in Triventures:
Name | Designation | Location | Board Memberships | Contact Details |
|---|---|---|---|---|
Partner | Israel | - | ||
Partner | Portola Valley | - | ||
Partner | United States | - | - | |
Principal | - | - |
Co-investors of Triventures
Over the past 15 years, 269 investors have co-invested in Triventures's portfolio companies. This includes funds and angels.
- Invested before Triventures: TLV Partners, Magma Venture Partners and 69 others have invested in rounds before Triventures. There is 1 company where TLV Partners has invested before Triventures and 1 company where Magma Venture Partners has invested before Triventures.
- Top Co-investors of Triventures: 87 investors entered a company along with Triventures. These include investors like Sanara Capital (2 companies).
- Invested after Triventures: A total of 111 investors have invested in Triventures's portfolio after their investments. Top Investors include Citi Impact Fund (2 companies), Consensus Business Group (2 companies) and Samsung NEXT (2 companies).
Recent News related to Triventures
•
Descope closes $88M Seed round with $35M extensionCTech•Sep 30, 2025•Descope, Notable Capital, Triventures, Dell Technologies Capital and 4 others
•
FEMSelect Secures Oversubscribed Series B Funding to Drive GrowthPR Newswire•May 13, 2025•Triventures, New Age Capital, FEMSelect
•
Cala® Health Closes Oversubscribed $50 Million Financing To Propel Growthintelligence360•Dec 23, 2024•Cala Health, Vertex Growth, Nexus NeuroTech Ventures, Johnson & Johnson and 9 others
•
Cala Health Raises $50M for Wearable Tremor TreatmentHIT Consultant•Dec 09, 2024•Cala Health, Vertex Growth, Nexus NeuroTech Ventures, Johnson & Johnson and 13 others
•
TailorMed raises $40 million in equity and debt to help patients access critical medicationsCTech•Nov 21, 2024•TailorMed, Windham Venture Partners, Samsung NEXT, Citi and 17 others
•
Monogoto nets $27 million Series A to power global connectivity solutionsCTech•Oct 15, 2024•Monogoto, Toyota Ventures, Samsung NEXT, Assembly Ventures and 11 others
•
Monogoto Raises $27 Million in Series A Funding to Lead the Software-Defined Connectivity Revolutionbignewsnetwork.com•Oct 15, 2024•Monogoto, Samsung NEXT, Assembly Ventures, Magenta Venture Partners and 7 others
•
Brightside Health Secures $33M to Expand Access to Mental HealthcareHIT Consultant•Mar 27, 2024•Brightside Health, S32, Time BioVentures, Kennedy Lewis Investment Management and 5 others
•
London-based Griffin secures €21.9 million to scale operations after banking license approvalEU-Startups•Mar 11, 2024•Griffin, FCA, MassMutual Ventures, NordicNinja and 8 others
•
Israel-based Pharma startup FeelBetter raises USD 5.9 million in fundingVcbay News•Aug 01, 2023•FeelBetter, Firstime, Shoni Health Ventures, Random Forest and 2 others
